We are live on ! Find out more
ELI

Empire Life Investments Portfolio holdings

AUM $1.79B
1-Year Est. Return 38.49%
This Fund
S&P 500
This Quarter Est. Return
+8.31%
1 Year Est. Return
+38.49%
3 Year Est. Return
+90.78%
5 Year Est. Return
+112.81%
10 Year Est. Return
AUM
$1.31B
AUM Growth
+$121M
Cap. Flow
+$31.5M
Cap. Flow %
2.39%
Top 10 Hldgs %
33.67%
Holding
108
New
16
Increased
68
Reduced
12
Closed
11

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$26.4M
2
PM icon
Philip Morris
PM
+$22.2M
3
JNJ icon
Johnson & Johnson
JNJ
+$19.6M
4
LOW icon
Lowe's Companies
LOW
+$13.4M
5
TXN icon
Texas Instruments
TXN
+$13.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$29.3M
2
JELD icon
JELD-WEN Holding
JELD
+$20.3M
3
BA icon
Boeing
BA
+$17.1M
4
BDX icon
Becton Dickinson
BDX
+$15.5M
5
SPR
Spirit AeroSystems
SPR
+$12.6M

Sector Composition

Rank Sector Weight
1 Healthcare 16.72%
2 Financials 15.07%
3 Communication Services 12.2%
4 Technology 11.36%
5 Consumer Staples 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKLN icon
101
Invesco Senior Loan ETF
BKLN
$6.77B
-24,777
Closed -$560K
CIBR icon
102
First Trust NASDAQ Cybersecurity ETF
CIBR
$16.2B
-16,718
Closed -$462K
DOW icon
103
Dow Inc
DOW
$20.9B
-101,207
Closed -$4.82M
MMM icon
104
3M
MMM
$83.6B
-21,166
Closed -$2.91M
RPM icon
105
RPM International
RPM
$12.9B
-90,254
Closed -$6.21M
SPR
106
DELISTED
Spirit AeroSystems
SPR
-153,154
Closed -$12.6M
PEGI
107
DELISTED
Pattern Energy Group Inc. Class A
PEGI
-393,101
Closed -$10.6M
CELG
108
DELISTED
Celgene Corp
CELG
-295,391
Closed -$29.3M

Similar funds

Empire Life Investments's Q4 2019 Portfolio in Review

As of Q4 2019, Empire Life Investments held 108 positions worth $1.31B, up 10% from $1.19B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Empire Life Investments's Q4 2019 filing shows 16 new, 68 increased, 12 reduced and 11 closed positions. Its largest new stake was Gilead Sciences: 404,632 shares worth $26.3M. The largest sale was Celgene Corp, an estimated $29.3M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 14% a quarter earlier, followed by Financials and Communication Services.

  • Empire Life Investments's largest Q4 2019 buy was Gilead Sciences: 404,632 shares worth $26.3M.
  • Empire Life Investments added most to Philip Morris in Q4 2019, an estimated $22.2M increase.
  • Empire Life Investments's biggest Q4 2019 reduction was JELD-WEN Holding, cutting an estimated $20.3M.
  • Empire Life Investments fully exited Celgene Corp in Q4 2019, selling an estimated $29.3M.
  • Empire Life Investments's ten largest holdings make up 34% of its $1.31B portfolio in Q4 2019.
  • Empire Life Investments opened 16 new positions and closed 11 in Q4 2019.
  • Empire Life Investments's portfolio value rose 10% quarter-over-quarter to $1.31B.

Based on Empire Life Investments's 13F filing for Q4 2019, filed 21 Jan 2020.